Effects of Limicol on LDL-cholesterol

Study of the Effects of Limicol (a Food Supplement) on LDL-cholesterol in Moderate Hypercholesterolemia Subjects

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT01354327

Enrollment

Registered

2011-05-16

Start date

2008-12-31

Completion date

2011-05-31

Last updated

2011-05-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypercholesteremia

Keywords

Delivery of Health Care, Cholesterol, LDL-cholesterol, Coronary artery disease, Red yeast rice, Plants extract, Cholesterol excess

Brief summary

The principal objective of this study is to investigate the effects of a novel food supplement (Limicol) on LDL-cholesterol levels in healthy subjects with moderate hypercholesterolemia.

Interventions

DIETARY_SUPPLEMENTLimicol

3 tablets / day during 4 months

DIETARY_SUPPLEMENTPlacebo

3 tablets / day during 4 months

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

TRIPLE (Subject, Caregiver, Investigator)

Eligibility

Sex/Gender

ALL

Age

18 Years to 55 Years

Healthy volunteers

Yes

Inclusion criteria

* About 18 to 55 years (inclusive) * Subject has a stable weight for at least three months before the start of the study * Subject able and willing to comply with the protocol and agreeing to give their consent in writing * Subject affiliated with a social security scheme * Subject willing to be included in the national register of volunteers who lend themselves to biomedical research

Design outcomes

Primary

Measure	Time frame
Change from Baseline in blood LDL-cholesterol levels at 4 months	4 months

Secondary

Measure	Time frame
Change from Baseline in blood Vit. C, Vit. E, polyphenols and MDA levels at 4 months	4 months

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026